The rationale for this new therapeutic approach is based on our current understanding of the role of IgE in immune func- tion and allergic diseases. Although it represents a treatment may only be effective in allergic asthmatics. The partial reduc- tion of some indices of inflammation is of importance, but more studies are needed in patients with a more severe form of the disease to asses the real importance of this treatment. Moreover, the route of administration probable will hamper The use of this novel treatment in patients with a milder form Of the disease.
展开▼
